SCHEDULE 13G/A

Inhibikase Therapeutics Inc

Common Stock, par value $0.001 per share · CUSIP: 45719W205

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Fairmount Funds Management LLC

  Shares: 7,018,575.00 · Class: 9.9%

• Fairmount Healthcare Fund II L.P.

  Shares: 7,018,575.00 · Class: 9.9%

• Peter Harwin

  Shares: 7,018,575.00 · Class: 9.9%

• Tomas Kiselak

  Shares: 7,018,575.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.